SCHEMBL6593239

SCHEMBL6593239

COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 1.00
DRD2 P14416 2/20 1.00
ADRA2B P18089 1/20 1.00
SIGMAR1 Q99720 1/20 1.00
HTR2C P28335 3/20 0.46
HTR2A P28223 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HTR7 P34969 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5674428 1.00 ADRA2A (1.00) ADRA2ADRD2ADRA2BSIGMAR1HTR2C
SCHEMBL29468692 1.00 ADRA2A (1.00) ADRA2ADRD2ADRA2BSIGMAR1HTR2C
SCHEMBL8319492 0.88 DRD2 (0.78) ADRA2ADRD2ADRA2BSIGMAR1HTR2C
SCHEMBL8326105 0.88 DRD2 (0.78) ADRA2ADRD2ADRA2BSIGMAR1RAB9A
SCHEMBL8325505 0.85 DRD2 (0.74) ADRA2ADRD2ADRA2BSIGMAR1MEN1
SCHEMBL8320289 0.84 DRD2 (0.73) ADRA2ADRD2ADRA2BSIGMAR1MAPT
SCHEMBL8321611 0.84 DRD2 (0.72) ADRA2ADRD2ADRA2BSIGMAR1
SCHEMBL8319263 0.81 DRD2 (0.68) ADRA2ADRD2ADRA2BSIGMAR1MAPT
SCHEMBL8323168 0.78 CYP3A4 (0.65) ADRA2ADRD2ADRA2BSIGMAR1HTR2C
SCHEMBL8324313 0.78 DRD2 (0.64) ADRA2ADRD2ADRA2BSIGMAR1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056720-B1 PHTALIMIDO ARYLPIPERAZINES AS ALPHA 1A RECEPTOR ANTAGONISTS USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ORTHO MCNEIL PHARM INC (US) 2004-10-20 EP disclosed